The surge in generative AI investment has so far centered on consumer and productivity software, but OpenEvidence highlights a shift toward specialized medical applications as hospitals and physicians increasingly rely on AI to support clinical decisions that can affect patient outcomes.
News
Medical AI startup OpenEvidence doubles valuation to $12 billion in latest round
January 22, 2026The surge in generative AI investment has so far centered on consumer and productivity software, but OpenEvidence highlights a shift toward specialized medical applications as hospitals and physicians increasingly rely on AI to support clinical decisions that can affect patient outcomes.